Serotonin receptor research has advanced significantly with the discovery of RH-34, also known by its chemical name, 3-(2-((2-Methoxybenzyl)amino)ethyl)quinazoline-2,4(1H,3H)-dione Hydrochloride. This molecule, with the CAS number 1028307-48-3, is gaining interest in neuropharmacological circles due to its unusual interaction with the 5-HT2A receptor.
cas: 1956369-26-8 RH-34 HCL
Metaxoxybenzyl compounds in pharmacology, 5-HT2A receptor and RH-34, Quinazolinedione derivatives in the central nervous system, and "RH-34 neuropharmacology" are examples of keywords that appear frequently in Google's Hot Search results.
Similar Products from Competitors Similar to other 5-HT2A receptor modulators, RH-34 shares its pharmacological landscape with risperidone and ketanserin. Nevertheless, there are discrete interactions with the receptor that are offered by its one-of-a-kind structural changes.
Health Advantages and Risks The capacity of RH-34 to modify the 5-HT2A receptor implies that it may have therapeutic uses in the treatment of illnesses including depression, anxiety, and schizophrenia that are linked to serotonin dysregulation, even though its primary purpose is research.
Product Design Mechanism An essential receptor in the central nervous system, RH-34 functions as a partial agonist at the 5-HT2A receptor. It's possible that this relationship changes a number of serotonin-related processes, which can help us understand complex neuropharmacological pathways.
Risks and Adverse Reactions On the other hand, the safety profile of RH-34 in human subjects has not been completely established since it is largely used for research. Handling and experimentation need caution. The possible adverse effects are probably associated with the way it interacts with serotonin pathways.
Dosage and Contraindications Since RH-34 is still mostly used in controlled study settings, exact dosing information and reasons why it shouldn't be used haven't been figured out yet.
In summary An intriguing case of molecular inventiveness, RH-34 opens up new vistas for the investigation of serotonin receptors and the functions they play in the brain. There is still a lot of potential in the field of medicinal uses, which is exciting.
"People Also Ask"
Section Q: What sets RH-34 different from other serotonin receptor modulators? A: The structural design of RH-34 is unique due to the N-(2-methoxybenzyl) addition, which confers distinctive partial agonist characteristics at the 5-HT2A receptor.
Q: Is RH-34 effective for treating mental health disorders? A: The interaction between RH-34 and serotonin pathways shows promise in investigating potential treatments for conditions such as depression or anxiety. To confirm its effectiveness and safety in such applications, however, considerable clinical study is necessary.
